Journal of Steroid Biochemistry and Molecular Biology, volume 98, issue 1, pages 78-89
New anabolic steroid illegally used in cattle—structure elucidation of 19-norchlorotestosterone acetate metabolites in bovine urine
B. Le Bizec
1
,
N Van Hoof
2
,
D Courtheyn
3
,
I Gaudin
1
,
M Van de Wiele
3
,
Emmanuelle Bichon
1
,
H De Brabander
2
,
F. ANDRÉ
1
1
LABERCA-Ecole Nationale Vétérinaire de Nantes, Route de Gachet, BP 50707, F-44307 Nantės Cedex 3, France
|
3
Federal Food Laboratory, Braemkasteelstraat 59, B-9050 Gentbrugge, Belgium
|
Publication type: Journal Article
Publication date: 2006-01-01
scimago Q2
wos Q3
SJR: 0.925
CiteScore: 8.6
Impact factor: 2.7
ISSN: 09600760, 18791220
PubMed ID:
16216493
Biochemistry
Molecular Biology
Cell Biology
Clinical Biochemistry
Molecular Medicine
Endocrinology
Endocrinology, Diabetes and Metabolism
Abstract
4-Chloro-estr-4-en-17-ol-3-one, trivially named 19-norclostebol acetate or 4-chloro-19-nortestosterone acetate (NClTA), has been identified on the European black market in the late 1990s for possible use in breeding animals. After oral and subcutaneous administration of NClTA to bovine, urine samples were collected over a period of three weeks, and chemical structure of main excreted urinary metabolites was determined. After oral administration, the most abundant metabolites were mainly reduced as 4-chloro-19-norandrostan-3xi-ol-17-one and 4-chloro-19-norandrostan-3xi,17xi-diol. They were identified until 1 week after administration. Following subcutaneous injection, 4-chloro-19-norandrostan-3xi-ol-17-one was again of major abundance, but so were 4-chloro-19-norandrost-4-ene-3xi,17xi-diol and 4-chloro-19-norandrost-4-en-3xi-ol-17-one. They were detected at least 3 weeks after administration. Whatever the route of administration, metabolites were found mainly glucurono-conjugated; the only exception was metabolite 4-chloro-19-norandrostan-3xi-ol-17-one which was identified both in the sulpho- and glucurono-fractions.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.